UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
ICF International
ICFI
$1.66B
| $2.1M | ﹤0.01% |
21,197
-2,978
| -12% | -$325K |
|
1452
OFG Bancorp
OFG
$2.2B
| $2.1M | ﹤0.01% |
76,150
+681
| +0.9% | +$18.7K |
|
|
NOVA
1453
DELISTED
Sunnova Energy
NOVA
| $2.09M | ﹤0.01% |
115,821
+3,165
| +3% | +$63.7K |
|
1454
Sonos
SONO
$1.83B
| $2.08M | ﹤0.01% |
123,193
+12,246
| +11% | +$199K |
|
1455
Axsome Therapeutics
AXSM
$11.4B
| $2.08M | ﹤0.01% |
26,954
+1,951
| +8% | +$117K |
|
1456
Cracker Barrel
CBRL
$1.25B
| $2.07M | ﹤0.01% |
21,841
-1,221
| -5% | -$127K |
|
1457
Impinj
PI
$5.39B
| $2.05M | ﹤0.01% |
18,788
-563,380
| -97% | -$59.3M |
|
1458
Ironwood Pharmaceuticals
IRWD
$669M
| $2.05M | ﹤0.01% |
165,354
+37,205
| +29% | +$422K |
|
|
CCC
1459
CCC Intelligent Solutions
CCC
$4.11B
| $2.05M | ﹤0.01% |
235,334
+140,192
| +147% | +$1.25M |
|
1460
Mueller Water Products
MWA
$4.07B
| $2.04M | ﹤0.01% |
189,984
+12,697
| +7% | +$142K |
|
1461
Supernus Pharmaceuticals
SUPN
$2.74B
| $2.04M | ﹤0.01% |
57,142
-1,555
| -3% | -$54K |
|
|
RXDX
1462
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.04M | ﹤0.01% |
18,524
+12,324
| +199% | +$799K |
|
1463
Verra Mobility
VRRM
$720M
| $2.04M | ﹤0.01% |
147,216
+27,981
| +23% | +$425K |
|
1464
Knowles
KN
$3.27B
| $2.03M | ﹤0.01% |
123,810
+20,474
| +20% | +$297K |
|
1465
WaFd
WAFD
$2.76B
| $2.03M | ﹤0.01% |
60,569
+872
| +1% | +$30.5K |
|
1466
QuantumScape Corp
QS
$3.81B
| $2.03M | ﹤0.01% |
357,652
+252,976
| +242% | +$1.87M |
|
|
OPTU
1467
Optimum Communications Inc
OPTU
$306M
| $2.03M | ﹤0.01% |
440,688
+16,224
| +4% | +$79.7K |
|
1468
Energizer
ENR
$1.5B
| $2.02M | ﹤0.01% |
60,316
-959
| -2% | -$29.5K |
|
1469
Green Plains
GPRE
$1.06B
| $2.01M | ﹤0.01% |
66,056
+10,901
| +20% | +$336K |
|
1470
NMI Holdings
NMIH
$3.32B
| $2.01M | ﹤0.01% |
96,188
-55
| -0.1% | -$1.15K |
|
1471
Huron Consulting
HURN
$2.42B
| $2.01M | ﹤0.01% |
27,678
+590
| +2% | +$43.4K |
|
1472
Caleres
CAL
$486M
| $2M | ﹤0.01% |
89,988
+15,877
| +21% | +$390K |
|
1473
Frontdoor
FTDR
$5.78B
| $2M | ﹤0.01% |
96,259
| – | – |
|
1474
Ginkgo Bioworks
DNA
$500M
| $1.99M | ﹤0.01% |
29,507
+6,939
| +31% | +$638K |
|
1475
BancFirst
BANF
$3.77B
| $1.99M | ﹤0.01% |
22,593
+1,012
| +5% | +$95.6K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.